![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/ablaze-pharmaceuticals-plans-development-of-innovative-gpc3-targeted-radiopharmaceutical-therapy-for-liver-cancer-in-greater-china-301786152.html
https://www.prnewswire.com/news-releases/ablaze-pharmaceuticals-and-yonghe-pharma-initiate-development-and-manufacturing-services-agreement-for-targeted-radiopharmaceutical-therapies-301709927.html
https://www.indianpharmapost.com/news/ablaze-and-yonghe-pharma-initiate-development-and-manufacturing-agreement-for-targeted-radiopharmaceutical-therapies-13512
https://www.contractpharma.com/contents/view_breaking-news/2022-08-08/ablaze-pharma-and-wenjiang-district-gov-of-chengdu-sign-strategic-agreement/?widget=listSection
https://www.prnewswire.com/news-releases/ablaze-pharma-aligned-the-strategic-agreement-with-wenjiang-district-government-of-chengdu-to-build-up-the-innovative-rd-and-manufacturing-center-for-targeted-radiopharmaceutical-therapies-301597950.html